Results 71 to 80 of about 365,101 (202)

Management of Sepsis-Induced Immunosuppression

, 2018
International audienceIt is now well established that profound immunosuppression develops within a few days after sepsis onset in patients. This should be considered additional organ failure because it is associated with increased rate of nosocomial ...
Thomas Rimmelé, Fabienne Venet, Guillaume Monneret, Venet, Fabienne, Monneret, Guillaume, Rimmelé, Thomas   +5 more
core   +1 more source

Immediate and Gradual Withdrawal of Immunosuppression After Kidney Graft Loss Lead to Similar Outcomes

Transplant International
The management of immunosuppression in dialysis patients with a failed kidney transplant remains a pending question, and different approaches to immunosuppression weaning have been proposed.
Asmaa Nabil, Asmaa Nabil, Nicolas Congy-Jolivet, Nicolas Congy-Jolivet, Nicolas Congy-Jolivet, Amandine Darres, Pierre Guy, Olivier Marion, Jean Milhes, Thomas Prudhomme, Thomas Prudhomme, Nassim Kamar, Nassim Kamar, Nassim Kamar, Arnaud Del Bello, Arnaud Del Bello, Arnaud Del Bello   +16 more
doaj   +1 more source

Case Report: Late-onset BK polyomavirus-associated nephropathy in kidney transplant recipients: two cases and insights into underlying mechanisms

Frontiers in Medicine
BK polyomavirus–associated nephropathy (BKPyVAN) results from primary infection or reactivation of BK polyomavirus (BKPyV) and remains a significant complication in kidney transplant recipients, contributing to allograft dysfunction and premature ...
Tanja Belčič Mikič, Tanja Belčič Mikič, Matic Bošnjak, Matic Bošnjak, Miha Arnol, Miha Arnol   +5 more
doaj   +1 more source

Enhancement of Cry1Ca toxicity by host immunosuppression.

, 2019
Enhancement of Cry1Ca toxicity by host immunosuppression.
Federica Astarita (6425474), Luca Gianfranceschi (326960), Anna Illiano (5099513), Angela Amoresano (363114), Silvia Caccia (241599), Pietro Pucci (1505599), David Horner (165490), Ilaria Di Lelio (667697), Paola Varricchio (158230), Francesco Pennacchio (158239)   +9 more
core   +1 more source

Conference recommendations on immunosuppression practice for adult liver transplantation in Egypt

Egyptian Liver Journal
Background Adult living donor liver transplantation (LDLT) started in Egypt in 2001, with more than 5000 cases transplanted since then. In Egypt using only ABO compatible donor is the practice in all cases, and up till now, the only oncological ...
Nahed A Makhlouf, Iman F Montasser, Rasha Refaie, Yasmine M Massoud, Ahmed Marwan, Ehab Abdel-Khalek, Hadeel Gamal Eldeen, Mohamad EL Tabbakh, Mohamed Said, Wahid Doss, Ayman Yosry, Mohamed Sherif Mogawer, Mohamed El-Saadany, Mohammad Amin Sakr, Imam Waked, Gamal Esmat   +15 more
doaj   +1 more source

From immunosuppression to tolerance

, 2015
SummaryThe past three decades have seen liver transplantation becoming a major therapeutic approach in the management of end-stage liver diseases. This is due to the dramatic improvement in survival after liver transplantation as a consequence of the ...
Samuel, Didier, Sanchez-Fueyo, Alberto; id_orcid, Alberto Sanchez-Fueyo, Sanchez-Fueyo, Alberto, Adams, David H, David H. Adams, Didier Samuel   +6 more
core   +1 more source

RSV prefusion F vaccine effectiveness in older adults with immunosuppression: a prespecified analysis of the DAN-RSV trial

The Lancet. Healthy Longevity
Summary: Background: Individuals with immunosuppression are at an increased risk of severe respiratory syncytial virus (RSV) disease. We aimed to evaluate the effectiveness of a bivalent RSV prefusion F protein-based vaccine (RSVpreF) in older adults ...
Anne Marie Reimer Jensen, MD, Mats C Højbjerg Lassen, MD, Niklas Dyrby Johansen, MD PhD, Sine H Christensen, MSc, Negar Aliabadi, MD MS, Kristoffer G Skaarup, MD, Daniel Modin, MD, Kira Hyldekær Janstrup, PhD, Brian L Claggett, PhD, Carsten S Larsen, MD DMSc, Lykke Larsen, MD PhD, Lothar Wiese, MD PhD, Michael Dalager-Pedersen, MD PhD, Matias G Lindholm, MD PhD, Maria Dons, MD PhD, Katrine F Bernholm, MD, Filip S Davidovski, MD, Lisa S Duus, MD, Camilla I Ottosen, MD, Anne B Nielsen, MD, Julie H Borchsenius, MD, Caroline Espersen, MD, Guldas Köse, MD, Frederik H Fussing, MD, Lars Køber, Prof, Scott D Solomon, Prof, Jens Ulrik Stæhr Jensen, Prof, Cyril Jean-Marie Martel, PhD, Bradford D Gessner, MD, Claudia Schwarz, PhD, Elisa Gonzalez, MS, Mette Skovdal, MSc, Pingping Zhang, MS, Elizabeth Begier, MD MPH, Tor Biering-Sørensen, Prof   +34 more
doaj   +1 more source

Regulation of soluble CD127 protein release and corresponding transcripts expression in T lymphocytes from septic shock patients

Intensive Care Medicine Experimental, 2019
Julie Mouillaux, Camille Allam, Thomas Rimmelé, Thomas Uberti, Benjamin Delwarde, Julien Textoris, Guillaume Monneret, Estelle Peronnet, Fabienne Venet   +8 more
doaj   +1 more source

Immunosuppression in stem cell clinical trials of neural and retinal cell types: A systematic review.

PLoS ONE
BackgroundPharmacologic immunosuppression regimes are commonly employed in stem cell clinical trials to mitigate host immune rejection and promote survival and viability of transplanted cells.
Shravan Gowrishankar, Matthew E Smith, Nathan Creber, Jameel Muzaffar, Daniele Borsetto   +4 more
doaj   +1 more source

Hepatitis B Virus (HBV) Reactivation Following Immunosuppression in HBsAg(+) Carriers [PDF]

, 2016
HBV reactivation occurs in HBsAg(+) carriers who have undergone immunosuppressive therapy such as Rituximab treatment, chemotherapy or corticosteroids for malignancy or other diseases that require immunosuppression.
Wu, Richard M, Hann, Hie-Won L
core